Pharma Colloquium - Advanced Executive Education on the Interface of Regulation  and Business Strategy for International Pharmaceutical Enterprises

Overview | Agenda | Continuing Education | Promotional Opportunities | Travel/Accommodations
Registration | Order CDs | Privacy Policy | Administration | Past Colloquia | Contact Us | Home


Advanced Executive Education on the Interface of Regulation and<BR>
Business Strategy for Global Pharmaceutical, Biotechnology and Medical Device Enterprises

Building on the runaway success of last year's program, which featured distinguished faculty from industry, government and academia, we are pleased to announce -

THE 2005 PHARMA, BIOTECH
AND DEVICE COLLOQUIUM

McCosh Hall
Princeton University
Princeton, New Jersey

June 6-8, 2005


SPONSORED BY
















COSPONSORS






































DIAMOND GRANTORS





GOLD GRANTORS



SILVER GRANTORS
















For future information about The Pharma, Biotech and Device Colloquium, please complete the form below.

First Name:
Last Name:
Email:

We subscribe to the HONcode principles of the HON Foundation. Click to verify.


Uwe E. Reinhardt, Ph.D.
James Madison Professor of Political Economy
Woodrow Wilson School, Princeton University

"It is my pleasure to welcome attendees of the Pharma, Biotech and Device Colloquium to the campus of Princeton University. I hope that you will enjoy this unique experience to contemplate strategic issues in the future of the pharmaceutical, biotechnology and medical device sectors with the assistance of the first rate Colloquium faculty."



KEYNOTE SPEAKERS

David Brailer, MD, Ph.D.
National Health Information Technology Coordinator, Department of Health and Human Services, Washington, DC
Carrie Cox
Executive Vice President and President, Global Pharmaceuticals, Schering-Plough Corporation, Kenilworth, NJ
James C. Greenwood
President and Chief Executive Officer, Biotechnology Industry Organization (BIO), Former Representative (R-Pa), United States House of Representatives, Washington, DC
Lewis Morris, Esq.
Chief Counsel, Office of Inspector General, Department of Health and Human Services, Washington, DC
Ian Morrison, Ph.D.
Senior Fellow, Institute for the Future, Founding Partner, Harris/Harvard Strategic Health Perspectives, Author, Healthcare in the New Millennium: Vision, Values and Leadership and The Second Curve: Managing the Velocity of Change, Menlo Park, CA
Donald J. Palmisano, MD, JD
Immediate Past President, American Medical Association, Founder and President, Intrepid Resources, Metairie, LA
Uwe E. Reinhardt, Ph.D.
James Madison Professor of Political Economy, Woodrow Wilson School, Princeton University, Princeton, NJ
Paul T. Antony, MD, MPH
Chief Medical Officer, Pharmaceutical Research and Manufacturers of America (PhRMA), Former Flight Surgeon and Senior Medical Officer, Marine Presidential Helicopter Squadron One, Washington, DC
Robert J. Donnelly
Director, Medicare Drug Benefit Group, Center for Beneficiary Choices, Centers for Medicare and Medicaid Services, Baltimore, MD
COLLOQUIUM CO CHAIRS

John T. Bentivoglio, Esq.
Partner, King & Spalding, Former Special Counsel for Healthcare Fraud and Chief Privacy Officer, United States Department of Justice, Washington, DC
Anthony L. Farino
Leader, Global Pharmaceutical Advisory Services Group, PricewaterhouseCoopers LLP, Chicago, IL
John K. Iglehart
Founding Editor, Health Affairs, National Correspondent, New England Journal of Medicine, Washington, DC
Keith M. Korenchuk, JD, MPH
Partner, McGuire Woods, Charlotte, NC
Steve Mohr, Esq.
Deputy Compliance Officer, AstraZeneca, Wilmington, DE
Brian Salsberg, JD
Associate Principal, Pharmaceutical and Medical Products Practice, McKinsey & Company, Florham Park, NJ
Brenton L. Saunders, JD, MBA
Senior Vice President, Global Compliance and Business Practices Schering-Plough Corporation, Past President, Health Care Compliance Association, Founder, International Association of Privacy Professionals, Kenilworth, NJ
Daniel E. Troy, Esq.
Partner, Sidley Austin Brown & Wood, Former Chief Counsel, Office of the General Counsel, Food and Drug Administration, Washington, DC

FEATURED FACULTY

Grant P. Bagley, MD, JD
Partner, Arnold & Porter, Former Director, Coverage and Analysis Group, HCFA Office of Clinical Standards and Quality, Washington, DC

Valli Baldassano
Vice President, Global Compliance, Commercial Operations Schering-Plough, Kenilworth, NJ

Paul F. Banta
Vice President, Law and Policy, Epocrates, Inc., San Mateo, CA

Diane Bergeron
Vice President, Consent Decree Management, Schering-Plough Corporation, Kenilworth, NJ

Katherine Binns
Senior Vice President, Health Care and Policy Research, Harris Interactive, New York, NY

Eric M. Blumberg, Esq.
Deputy Chief Counsel, Litigation, Office of Chief Counsel, Food and Drug Administration, Rockville, MD

Ray Bonner, Esq.
Partner, Sidley Austin Brown & Wood, Washington, DC

Janice K. Bush, MD
Vice President, Quality, Education and Business Support, Benefit Risk Management, Johnson & Johnson Pharmaceuticals, Immediate Past Chair, PhRMA Pharmacovigilance and Epidemiology Technical Committee, Titusville, NJ

Austin B. Byrd, Esq., Sr.
Corporate Counsel, Compliance, Smith & Nephew, Inc., Memphis, TN

Carlo di Florio, JD
Director, Advisory Services, PricewaterhouseCoopers, LLP, New York, NY

Terry Dwyer
Vice President Quality and Compliance, PSGA, A Division of Ortho McNeil, Bridgewater, NJ

Mike Ferrante
Director, PricewaterhouseCoopers LLP, Florham Park, NJ

Markus Gemuend
Vice President, Manaufacturing, Collaboration and Contracts Manufacturing
Genentech, South San Francisco, CA


Stephen A. Goldman, MD, FAPM, FAPA
Managing Member, Stephen A. Goldman Consulting Services, L.L.C., Former Medical Director, MedWatch, Food and Drug Administration, Morris Plains, NJ

Clifford Goodman, Ph.D.
Vice President, The Lewin Group, Falls Church, VA

John K. Gorman
President and Chief Executive Officer, Gorman Health Group, LLC, Former Press Secretary and Staff Director, US Representative John Conyers, Jr. (D-MI) and Former Assistant to the Director, HCFA's Office of Managed Care, Washington, DC

Bill Healey
Executive Vice President, HealthCare Institute of New Jersey, Hillside, NJ

Jonathon Kellerman
Senior Manager, PricewaterhouseCoopers, Philadelphia, PA

Brian Kelly
Executive Director, Development Operations Group, Merck and Company, West Point, PA

Kathy Lundberg
Senior Vice President and Chief Compliance Officer, Guidant Corporation, St. Paul, MN

Aamir Malik
Principal, Pharmaceutical and Medical Products Practice, McKinsey & Company, Florham Park, NJ

Jay P. Mayesh, Esq.
Partner, Litigation, Co-Chair, Product Liability, Kaye Scholer, LLP, New York, NY

Angus McCulloch
Principal, Life Sciences Practice, WCI Group, New York, NY

Louise Mehrotra
Worldwide Vice President, Healthcare Compliance, Johnson & Johnson, New Brunswick, NJ

Nancy Miller-Rich
Vice President, Business Development, Schering-Plough Consumer Health, Berkeley Heights, NJ

Scott L. Mitchell
President and Chief Executive Officer, Open Compliance and Ethics Group, Scottsdale, AZ

David Moskowitz, MBA, R.Ph.
Senior Vice President and Healthcare Senior Analyst, Friedman, Billings, Ramsey Group, Inc., Arlington, VA

David Nexon
Senior Executive Vice President, Advanced Medical Technology Association (AdvaMed), Washington, DC

Ronald Piervincenzi
Associate Principal, Pharmaceuticals and Medical Products Practice, McKinsey & Company, Florham Park, NJ

Claudio Pincus
President, The Quantic Group, Livingston, NJ

Lori Queisser
Vice President and Chief Compliance Officer, Eli Lilly and Company, Indianapolis, ID

Retta Riordan
Business Ethics and Compliance Officer, Organon Pharmaceuticals, Roseland, NJ

Matthew Robin, M.Eng.
Chief Executive Officer, Ypsomed, Advisor, BVGroup Private Equity, Switzerland

Marissa Seligman
Vice President, M/C Communications (Pri-Med Institute), Boston, MA

John Simons
Writer, Fortune Magazine, Washington, DC

Jean Slutsky
Director, Center for Outcomes and Evidence, Agency for Healthcare Research and Quality, Rockville, MD

Dalton Smart
Director, Global Compliance and Business Practices, Schering-Plough, Kenilworth, NJ

Janet Steiner
Senior Director, Compliance & Ethics, Clinical Development, AstraZeneca, Wilmington, DE

Douglas S. Strang, CPA, MBA
Partner, PricewaterhouseCoopers, Philadelphia, PA

Julie K. Taitsman, M.D., J.D.
Senior Counsel, Industry Guidance Branch, Office of Counsel to the Inspector General, Department of Health and Human Services, Washington, DC

Shinya Yamauchi
Director, Global Pharmacovigilance, Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan


Overview | Agenda | Continuing Education | Promotional Opportunities | Travel/Accommodations
Registration | Order CDs | Privacy Policy | Administration | Past Colloquia | Contact Us | Home

All material on this website is protected by copyright.
Copyright @ 2005 by Health Care Conference Administrators, LLC.
All rights reserved.

Contact Webmaster